Endocrine oncology

Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Related to a Poor Outcome: A Comparison Study Using Propensity Score Matching

Endocr PractPublished Retrospective cohort study

Main finding · Persistent/recurrent diseaseResult — go to the resultOdds ratio 6.288 95% CI 1.900–20.811

Authors' conclusion

This propensity score-matched analysis found that the histologic type of DSV-PTC may increase the risk of persistent/recurrent disease.

Study context

Population
Patients with PTC after postoperative RAI therapy35 diffuse sclerosing variant of papillary thyroid carcinoma (DSV-PTC) and 240 classic variant of papillary thyroid carcinoma (CV-PTC) included
Participants
35 vs 105
Exposure
DSV-PTC vs CV-PTC
  • DSV-PTCn = 35
  • CV-PTCn = 105reference
Outcome
Persistent/recurrent disease
Methodological detailspropensity score matching (1:3 matching ratio)
  • Propensity score matching (1:3 matching ratio)

Main finding

As reported in the abstract

Odds ratio

6.288

95% CI 1.900–20.811

P = 0.003

By group

DSV-PTCvs CV-PTC
OR 6.288 (95% CI 1.900–20.811); P = 0.003

Observational data: associations, not effects.

Further findings

5-year DFS · shorter DFS with DSV-PTC (Kaplan-Meier)

P = 0.001

Original publication

Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Related to a Poor Outcome: A Comparison Study Using Propensity Score Matching. Endocr Pract. Published 9 May 2023. doi:10.1016/j.eprac.2023.05.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.